Physician profile
John C Hancock
NPI 1790930352
$830.18
in general payments reported to CMS, 2019-2025
19 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $48.07 · 2021: $64.58 · 2022: $163 · 2023: $120 · 2024: $66.57 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $184.45 | 2019-2025 | |
| Novo Nordisk INC | $110.12 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $107.52 | 2021-2025 | Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $82.94 | 2019-2022 | |
| Dexcom, INC. | $50.27 | 2024-2025 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $41.78 | 2022 | |
| Merck Sharp & Dohme LLC | $39.92 | 2019 | |
| Allergan, INC. | $35.22 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $18.85 | 2019 | |
| Advanced Respiratory, INC | $18.78 | 2019 | |
| Philips North America LLC | $18.26 | 2021 | |
| Vapotherm INC | $16.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.82 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.56 | 2021 | |
| Glaxosmithkline, LLC. | $15.26 | 2025 | Shingrix, Arexvy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.15 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $14.55 | 2025 | Zepbound, Mounjaro |
| Abbvie INC. | $13.44 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.